Food contact notification to FDA

Biotage AB (publ) through its subsidiary MIP Technologies AB submits Food Contact Notification (FCN) to U.S. Food and Drug Administration (FDA)

Biotage acquired MIP Technologies in 2010 to gain access to world class development capabilities of custom designed molecular imprinted and other novel polymers. Following the acquisition Biotage has invested in the industrialization of MIP Technologies’ business operations. MIP Technologies is in the process of developing a range of Industrial Resins for use within food and related industries.

MIP Technologies has now submitted a Food Contact Notification (FCN) to U.S. Food and Drug Administration (FDA) for the product RENSA™ 101, which may be used for removal of unwanted impurities in flavoring oils that are used in food. The approval process with the FDA is expected to be finalized in Q2 2013.

“There is such a great need for products that can enhance food security by taking out substances that might be harmful to human. I am really pleased to see that we are part of that movement. It is yet early days for RENSA 101, but we hope that this product eventually will be commercialized in an industrial scale setting. We believe in this business and we will continue to invest. “, says Torben Jörgensen, CEO & President of Biotage.

Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84,

Tel+46 18 56 59 00

Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 10.00 on Monday 4 March 2013.

About Biotage
Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The company is headquartered in Uppsala and has offices in the US, UK, China and Japan. Biotage has approx. 290 employees and had sales of 463 MSEK in 2012. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website:

About Us

Biotage offers efficient separation technologies from analysis to industrial-scale and high-quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by public authorities, academic institutions, contract research and contract manufacturing organizations and in the pharmaceutical and food industries, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan, South Korea and India. Biotage has approx. 390 employees and had sales of 748 MSEK in 2017. Biotage is listed on Nasdaq Stockholm. Website:


Documents & Links